Reverse cardio-oncology: A budding concept

Having established the significance of cardiovascular side-effects of anti-neoplastic drugs, present day cardio-oncology has forayed into newer territories buoyed by research into the multiple connections that exist between cardiovascular disease and cancer. An emerging concept of reverse cardio-oncology focuses on the heightened risk of cancer in patients with cardiovascular disease. Common mechanistics of cancer and heart failure (HF) like chronic inflammation and clonal haematopoesis as well as common predisposing factors like obesity and diabetes underline the relation between both cardiovascular disease and various cancers.This review discusses the potential magnitude of the problem, the underlying pathophysiological mechanisms and classification of this novel subject.

• Publication year

  2023

• Venue

  Indian Heart Journal

• Publication date

  2023-09-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.ihj.2023.09.004PMID 37774949PMCID 10774571
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evolving field of cardio-oncology

  2023cited by this paper
• Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology

  2022cited by this paper
• Cancer incidence estimates for 2022 & projection for 2025: Result from National Cancer Registry Programme, India

  2022cited by this paper
• MicroRNAs in Cancer and Cardiovascular Disease

  2022cited by this paper
• Diabetes and Cancer: Risk, Challenges, Management and Outcomes

  2021cited by this paper
• Cyclophosphamide arrhythmogenicitytesting using human-induced pluripotent stem cell-derived cardiomyocytes

  2021cited by this paper
• Hypercholesterolemia Is an Associated Factor for Risk of Differentiated Thyroid Cancer in Chinese Population

  2021cited by this paper
• Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure

  2021cited by this paper
• A new classification of cardio-oncology syndromes

  2021cited by this paper
• Oxidative Stress in Radiation-Induced Cardiotoxicity

  2020cited by this paper
• Myocardial infarction accelerates breast cancer via innate immune reprogramming

  2020cited by this paper
• Inflammation: a common contributor to cancer, aging, and cardiovascular diseases—expanding the concept of cardio-oncology

  2019cited by this paper
• Metabolism, Epigenetics, and Causal Inference in Heart Failure.

  2019cited by this paper
• The anti-cancer drug doxorubicin induces substantial epigenetic changes in cultured cardiomyocytes.

  2019cited by this paper
• Increased cancer risk after myocardial infarction: fact or fiction? A systemic review and meta-analysis

  2019cited by this paper
• The obese adipose tissue microenvironment in cancer development and progression

  2018cited by this paper
• The Role of Apelin in Cardiovascular Diseases, Obesity and Cancer

  2018cited by this paper
• Heart Failure Stimulates Tumor Growth by Circulating Factors

  2018influential reference
• Impact of Heart Failure on Cancer Incidence: A Complicated Question.

  2018cited by this paper
• Cardiovascular and Cancer Risk: The Role of Cardio-oncology

  2018cited by this paper
• The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells

  2017cited by this paper
• Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life.

  2017cited by this paper
• Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.

  2017cited by this paper
• Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy

  2017cited by this paper
• 3106Patients with a diagnosis of hyperlipidaemia have a reduced risk of developing breast cancer and lower mortality rates: a large retrospective longitudinal cohort study from the UK ACALM registry

  2017cited by this paper
• The Role of Cholesterol in Cancer.

  2016cited by this paper
• Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults.

  2016cited by this paper
• Tumor-Induced Hyperlipidemia Contributes to Tumor Growth

  2016cited by this paper
• Risk of Malignant Cancer Among Women With New-Onset Atrial Fibrillation.

  2016cited by this paper
• The cardioprotective effects of L-carnitine on rat cardiac injury, apoptosis, and oxidative stress caused by amethopterin

  2016cited by this paper
• Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma.

  2015cited by this paper
• The dose–response effect of physical activity on cancer mortality: findings from 71 prospective cohort studies

  2015cited by this paper
• Atrial Fibrillation as a Marker of Occult Cancer

  2014cited by this paper
• Cisplatin in cancer therapy: molecular mechanisms of action.

  2014cited by this paper
• Acute changes in endothelial function with cisplatin among germ cell tumor (GCT) patients (Pts).

  2014cited by this paper
• CC Chemokine Receptors and Chronic Inflammation—Therapeutic Opportunities and Pharmacological Challenges

  2013cited by this paper
• Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis

  2012cited by this paper
• Blood Pressure and Risk of Cancer Incidence and Mortality in the Metabolic Syndrome and Cancer Project

  2012cited by this paper
• Identification of the molecular basis of doxorubicin-induced cardiotoxicity

  2012cited by this paper
• Chronic oral exposure to the aldehyde pollutant acrolein induces dilated cardiomyopathy.

  2011cited by this paper
• Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.

  2011cited by this paper
• Diabetes and Cancer: A Consensus Report

  2010cited by this paper
• Epidemiology and risk factors for kidney cancer

  2010cited by this paper
• Decreased Oxygen Transfer Capacity of Erythrocytes as a Cause of 5-Fluorouracil Related Ischemia

  2008cited by this paper
• Anthracycline cardiotoxicity.

  2008cited by this paper
• Thiazolidinediones and cardiovascular outcomes in older patients with diabetes.

  2007cited by this paper
• Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

  2003cited by this paper
• Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

  2002cited by this paper
• Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase.

  1986cited by this paper

• Cardiovascular disease as a contributing cause of cancer mortality: A population-based analysis of United States death certificate data (1999-2020).

  2026cites this paper
• IMPLICATION OF CARDIOVASCULAR PATHOLOGY ON THE RISKS OF THROMBOEMBOLIC COMPLICATIONS IN CANCER PATIENTS

  2025cites this paper
• Cardiovascular diseases and malignant neoplasms — what do they have in common?

  2025cites this paper
• Evolving Perspectives in Reverse Cardio-Oncology: A Review of Current Status, Pathophysiological Insights, and Future Directives.

  2024cites this paper
• The bidirectional association between cardiovascular disease and cancer: Is there an increased risk of cancer among heart failure patients?

  2024cites this paper
• Common biological processes and mutual crosstalk mechanisms between cardiovascular disease and cancer

  2024cites this paper